Trials Offered by a Specific Doctor

Andrew Lassman, MD
(212) 342-0571

Andrew B. Lassman, MD, is the John Harris Associate Professor of Neurology and the Chief of Neuro-oncology at Columbia University. After earning BS and MS degrees in Molecular Biophysics and Biochemistry as part of a combined 4-year program at Yale University, he received his MD from Columbia University College of Physicians and Surgeons. Dr. Lassman subsequently completed his residency at the Neurological Institute of NewYork-Presbyterian Hospital/Columbia University Medical Center, and fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center, where he then joined the faculty and served as fellowship director.

In November 2011, Dr. Lassman became Chief of Neuro-Oncology at Columbia University Medical Center, and also serves as the Medical Director for the Clinical Protocol Data Management Office of the Herbert Irving Comprehensive Cancer Center.

Dr. Lassman received the Preuss Award in Neuro-Oncology from the American Academy of Neurology, the Boyer Clinical Research Award from Memorial Sloan-Kettering Cancer Center, and the Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer. His clinical practice is limited to central nervous system tumors and metastases.

Clinical Studies Managed By Dr. Lassman:
More InfoTitleSponsorIRB Number
Details[CLOSED] A study for patients with HER2 positive breast cancer using study drug Trastuzumab for treatmentNorthwestern UniversityAAAO4157
DetailsA study for patients with glioblastoma using study drug ABT-414AbbVieAAAQ2302
Details[CLOSED] A study for patients with malignant glioblastoma or glioma using study drug PF-06840003PfizerAAAR0112
DetailsStudy of the efficacy and safety of Selinexor (KPT-330) in patients with recurrent gliomasNPM Pharma LTDAAAM6851